These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33577782)

  • 21. Advance in herpes simplex viruses for cancer therapy.
    Liu S; Dai M; You L; Zhao Y
    Sci China Life Sci; 2013 Apr; 56(4):298-305. PubMed ID: 23564184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fighting fire with fire: rewiring tumor cells for oncolytic virotherapy.
    Mahoney DJ; Stojdl DF
    Future Oncol; 2012 Mar; 8(3):219-21. PubMed ID: 22409457
    [No Abstract]   [Full Text] [Related]  

  • 23. Oncolytic adenovirus: A tool for reversing the tumor microenvironment and promoting cancer treatment (Review).
    Wang X; Zhong L; Zhao Y
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33760203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncolytic viruses: what to expect from their use in cancer treatment.
    Terrível M; Gromicho C; Matos AM
    Microbiol Immunol; 2020 Jul; 64(7):477-492. PubMed ID: 31663631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Designer nanocarriers for navigating the systemic delivery of oncolytic viruses.
    Howard F; Muthana M
    Nanomedicine (Lond); 2020 Jan; 15(1):93-110. PubMed ID: 31868115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological therapy with oncolytic herpesvirus.
    Benencia F; Coukos G
    Adv Exp Med Biol; 2008; 622():221-33. PubMed ID: 18546631
    [No Abstract]   [Full Text] [Related]  

  • 27. Cancer-fighting viruses win approval.
    Ledford H
    Nature; 2015 Oct; 526(7575):622-3. PubMed ID: 26511559
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical development directions in oncolytic viral therapy.
    Eager RM; Nemunaitis J
    Cancer Gene Ther; 2011 May; 18(5):305-17. PubMed ID: 21436867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential and clinical translation of oncolytic measles viruses.
    Robinson S; Galanis E
    Expert Opin Biol Ther; 2017 Mar; 17(3):353-363. PubMed ID: 28129716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncolytic viruses targeting tumor stem cells.
    Chiocca EA; Blair D; Mufson RA
    Cancer Res; 2014 Jul; 74(13):3396-8. PubMed ID: 24753541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular basis of herpesviruses as oncolytic agents.
    Menotti L; Campadelli-Fiume G; Nanni P; Lollini PL; De Giovanni C
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1795-803. PubMed ID: 21740356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genetic, immunological, and pharmacological strategies to generate improved oncolytic viruses].
    Pol J; Le Bœuf F; Diallo JS
    Med Sci (Paris); 2013 Feb; 29(2):165-73. PubMed ID: 23452603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncolytic herpes simplex virus engineering and preparation.
    Agarwalla PK; Aghi MK
    Methods Mol Biol; 2012; 797():1-19. PubMed ID: 21948465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral cancer therapies: are they ready for combination with other immunotherapies?
    Boisgerault N; Grégoire M; Fonteneau JF
    Future Oncol; 2017 Aug; 13(18):1569-1571. PubMed ID: 28776392
    [No Abstract]   [Full Text] [Related]  

  • 35. Recombinant viruses with other anti-cancer therapeutics: a step towards advancement of oncolytic virotherapy.
    Lal G; Rajala MS
    Cancer Gene Ther; 2018 Oct; 25(9-10):216-226. PubMed ID: 29735993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Editorial: Oncolytic Virus and Gene Thearapy Application: Update 2018.
    Abei M
    Curr Cancer Drug Targets; 2018; 18(2):108. PubMed ID: 29457568
    [No Abstract]   [Full Text] [Related]  

  • 37. Panorama from the oncolytic virotherapy summit.
    Pol JG; Marguerie M; Arulanandam R; Bell JC; Lichty BD
    Mol Ther; 2013 Oct; 21(10):1814-8. PubMed ID: 24081122
    [No Abstract]   [Full Text] [Related]  

  • 38. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
    Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
    Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategies for enhancing intratumoral spread of oncolytic adenoviruses.
    Goradel NH; Negahdari B; Ghorghanlu S; Jahangiri S; Arashkia A
    Pharmacol Ther; 2020 Sep; 213():107586. PubMed ID: 32479843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncolytic Virotherapy by HSV.
    Watanabe D; Goshima F
    Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.